This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

ITM Symposium on Actinium-225 Targeted Radionuclide Therapy at Theranostics World Congress

Actinium-225 Targeted Radionuclide Therapy – Current Perspective and Future Outlooks

Thank you for your interest in ITM’s symposium “Actinium-225 Targeted Radionuclide Therapy – Current Perspective and Future Outlooks” from the Theranostic World Congres 2022.

A recording of the symposium and the ensuing discussion is available to Healthcare Professionals here: View full recording

The symposium titled, “Actinium-225 Targeted Radionuclide Therapy – Current Perspective and Future Outlooks” will take place on June 25, from 11:30 am to 12:55 pm CET. Participants can attend in person or join via live stream, which will be available on the TWC website ahead of the congress.

The event will feature expert speakers, Prof. Matthias Eiber, Associate Professor, Clinic and Polyclinic for Nuclear Medicine, Klinikum rechts der Isar, TU Munich, Prof. Katharina Lückerath, Preclinical Theranostics, Clinic for Nuclear Medicine, University Hospital Essen and Neil Quigley, Global Product Manager at ITM.


Programm 6th Theranostics World Congress

TWC Official Website


Symposium Program & Speakers


An Evaluation of Current and Prospective 225Ac Production Methods
Neil Quigley, Global Product Manager, ITM, Garching / Munich

225Ac-PSMA for the Treatment of Prostate Cancer – Preclinical Experience
Prof. Katharina Lückerath, University Hospital Essen

Current Clinical Experience for 225Ac-PSMA in mCRPC
Prof. Matthias Eiber, Klinikum rechts der Isar, Technical University of Munich